|
Volumn 13, Issue , 2012, Pages
|
Discontinuation of reimbursement of benzodiazepines in the Netherlands: Does it make a difference?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANXIOLYTIC AGENT;
BENZODIAZEPINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
CLINICAL PRACTICE;
COST CONTROL;
ECONOMICS;
FEE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
NETHERLANDS;
STATISTICAL MODEL;
ADULT;
AGED;
ANTI-ANXIETY AGENTS;
BENZODIAZEPINES;
COST CONTROL;
FEMALE;
HUMANS;
LINEAR MODELS;
MALE;
MIDDLE AGED;
NETHERLANDS;
PHYSICIAN'S PRACTICE PATTERNS;
PRESCRIPTION FEES;
MLCS;
MLOWN;
|
EID: 84869219373
PISSN: None
EISSN: 14712296
Source Type: Journal
DOI: 10.1186/1471-2296-13-111 Document Type: Article |
Times cited : (16)
|
References (8)
|